Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Pre-Conference Ticketed Event

APA Award Winner

APS Award Winner

ASPN Award Winner

SPR Award Winner

On Demand Presentation

Poster Icons

SPR Award Winner

Back

734 Views

Evaluation ViewAttendees 69

Clubs

Academic and Research Skills

Advocacy

Awards

Basic Science

Breastfeeding/Human Milk

Children with Chronic Conditions

Clinical Research

Community Pediatrics

Critical Care

Developmental and Behavioral Pediatrics

Diversity, Equity, and Inclusion

Epidemiology

Gastroenterology/Hepatology

General Pediatrics

Global Neonatal & Children's Health

Health Equity/Social Determinants of Health

Health Services Research

Hematology/Oncology

Immigrant Health

Neonatology

Public Health

Quality Improvement/Patient Safety

Telemedicine

Well Newborn

Wellness and Well-being

Session Type: Clubs in Convention Center

Bilirubin Club

Saturday, May 4, 2024

12:30 PM – 2:00 PM ET

Location: Metro Toronto Convention Centre: 203

CE: Live CME: 1.5

Chair(s)

Timothy Bahr, MD

Assistant Professor of Pediatrics
Pediatrics
Intermountain Health/University of Utah
Salt Lake City, Utah, United States

Disclosure(s):

Timothy M. Bahr, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Session

Description: The Bilirubin Club is a global academic forum to discuss, debate and delve into the biology of bilirubin in the context of research, clinical practice, public policy and therapeutics to promote human well-being. These matters include the understanding of fetal and neonatal hemolysis, inherited red blood cell disorders including glucose-6-phosphate dehydrogenase (G6PD) deficiency as well as disorders of the enterohepatic bilirubin circulation and bilirubin conjugation that are aggravated by increasing prematurity. With contributions from bioengineers, biochemists, nurses, and global health researchers. affordable transformative neonatal public health policies? initiatives? guidelines? were formed and introduced in their populations, which have saved lives, prevented brain damage, reduced the need for blood exchange transfusion, and promoted maternal bonding at bedside and implementation of effective, rapid response to timely and safe phototherapy. This has been a noble collective health journey and it is also time to take stock of the evidence to implement and consolidate? novel safety measures, minimize the over-use of interventions, and continue to seek proven alternative global health care approaches both ethically and equitably.

Learning Objectives:

To learn about the pioneering contributions of researchers and champions who have promoted the clinical understanding of bilirubin.
To be updated on the ongoing advances in the research, technologies and clinical interventions to promote infant and child health.
To network with colleagues from diverse disciplines, geographies and cultures and to use this forum to collaborate, integrate and advance best clinical practices world-wide.

Presentations:

12:30 PM – 12:40 PM ET

Introduce Discussion of the Advances in "Pixels" of Jaundice for Telehealth
Speaker: Timothy M. Bahr, MD – Intermountain Health/University of Utah
12:40 PM – 12:45 PM ET

Lois H. Johnson and her Champions of Bilirubin
Speaker: Ronald J. Wong, MD – Stanford University School of Medicine
12:45 PM – 12:55 PM ET

Introduce Discussion of the Advances in "Physics" of Jaundice for Telehealth
Speaker: Daniele De luca, MD, PhD (he/him/his) – Paris Saclay University
12:55 PM – 1:05 PM ET

Mount Sinai Newborn G6PD screening Strategy
Speaker: Sarah Milburn, MD – Icahn School of Medicine at Mount Sinai
1:05 PM – 1:20 PM ET

Telehealth of Newborn Jaundice
Speaker: Tina M. Slusher, MD, FAAP (she/her/hers) – University of Minnesota Medical School